20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T21854 | Proteasome inhibitor IX | PS-IX,AM114 | Proteasome |
Proteasome inhibitor IX (PS-IX) is an inhibitor of chymotrypsin-like activity of the 20S proteasome (IC50 ~1 μM). Proteasome inhibitor IX shows potent anticancer activity. Proteasome inhibitor IX exhibits HCT116 p53+/+ c... | |||
T63321 | 20S Proteasome activator 1 | Proteasome | |
20S Proteasome activator 1 is a 20S proteasome activator with IC50 of 0.3 μM for trypsin-like sites, 0.7 μM for chymotrypsin-like sites and 1.8 μM for caspase sites. 20S Proteasome activator 1 prevents the accumulation o... | |||
T12561 | Proteasome-IN-1 | Proteasome | |
Proteasome-IN-1 is an inhibitor of proteasome. | |||
T81371 | Proteasome-IN-5 | Proteasome | |
Proteasome-IN-5, also known as compound 5, acts as a proteasome inhibitor [1]. | |||
T72762 | Proteasome-IN-4 | ||
Proteasome-IN-4, a non-covalent proteasome inhibitor (IC 50 = 8.39 nM), exhibits potent antiproliferative effects on RPMI-8226, MM-1S, and MV-4-11 cell lines, making it valuable for cancer research. | |||
T71092 | Proteasome-IN-3 | ||
Proteasome-IN-3 is an inhibitor of proteasome-associated DUBs. | |||
T81372 | Proteasome-activating peptide 1 | ||
Proteasome-activating peptide 1 enhances chymotrypsin-like proteasomal catalytic activity, boosting proteolytic rates both in vitro and within cultured cells. Additionally, it inhibits protein aggregation in a cellular m... | |||
T62255 | 20S Proteasome-IN-4 | ||
20S Proteasome-IN-4 (Compound 7) is an orally active inhibitor of the 20S proteasome, selectively targeting the parasite form and demonstrating brain penetration capabilities. It exhibits a potent IC50 value of 6.3 nM ag... | |||
T76243 | Proteasome-activating peptide 1 TFA | ||
Proteasome-activating peptide 1 TFA is a potent activator of the proteasome, enhancing chymotrypsin-like proteasomal catalytic activity and thereby increasing proteolytic rates both in vitro and in culture. Additionally,... | |||
T81373 | Proteasome β2c/i-IN-1 | Proteasome | |
Proteasome β2c/i-IN-1 (compound 37) serves as a selective inhibitor targeting the β2c and β2i subunits of the human proteasome [1]. | |||
T9710 | Dazcapistat | Cysteine Protease | |
Dazcapistat is a potent calpain inhibitor, with IC50s of <3 μM for calpain 1, calpain 2 and calpain 9, respectively. | |||
T78625 | Z-Ala-Arg-Arg-AMC | Z-ARR-AMC,Fluorogenic Proteasome Substrate | Proteasome |
Z-Ala-Arg-Arg-AMC (Fluorogenic Proteasome Substrate) serves as a fluorogenic substrate designed to assay the trypsin-like activity within the proteasome [1]. | |||
T6432 | Calpeptin | Apoptosis , Cysteine Protease , Proteasome | |
Calpeptin is a potent, cell-permeable calpain inhibitor. | |||
T9090 | MUN57694 | Proteasome | |
MUN57694 is an inhibitor of 26S proteasome. | |||
T7016 | VR23 | Apoptosis , Proteasome , Caspase | |
VR23 is a potent proteasome inhibitor. Data shows IC50 =1 nM for trypsin-like proteasomes, IC50=50-100 nM for chymotrypsin-like proteasomes, and IC50=3 μM for caspase-like proteasomes. | |||
T13858 | RA190 | Proteasome | |
RA190 inhibits proteasome function by covalently binding to cysteine 88 of ubiquitin receptor RPN13. | |||
T3786 | Tomatine | lycopersicin | Apoptosis , Proteasome |
Tomatine (lycopersicin) is an antiproliferatve agent of breast adenocarcinoma cells. | |||
T7814 | Alloxan monohydrate | Proteasome | |
Alloxan Monohydrate is a glucose analog used to induce diabetes by destroying beta-cells. | |||
T2122 | Ixazomib | MLN2238 | Proteasome , Caspase , Autophagy |
Ixazomib (MLN2238) , a second generation, boron-containing peptide proteasome inhibitor (PI), inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome (IC50/Ki: 3.4/0.93 nM, in cell-free assays), also i... | |||
T6941 | PI-1840 | PI 1840 | PARP , Proteasome |
PI-1840(IC50 = 27 nM)is a reversible and selective chymotrypsin-like (CT-L) inhibitor, with little proteasome proteolytic effects on trypsin-like (T-L) and postglutamyl-peptide-hydrolysis-like (PGPH-L). |